{
  "id": 16365576,
  "title": "Atacicpet, Sibeprenlimab Halt Decline in Kidney Function in IgA Nephropathy",
  "url": "https://urgent.news/2026/10/24/atacicpet-sibeprenlimab-halt-decline-in-kidney-function-in-iga",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-24T19:05:29.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/meetingcoverage/asn/123564"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- DENVER -- Two IgA nephropathy drugs -- atacicept (Trutakna) and sibeprenlimab injection (Voyxact) -- showed they were able to slow kidney function decline in final phase III trial efficacy analyses. Atacicept and sibeprenlimab...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}